BG Medicine Inc. (NASDAQ: BGMD), a U.S.-based company providing drug research and development services, is up sharply in mid-day trading today following the huge rally on Tuesday.
BGMD had surged more than 154% on Tuesday after the company announced that obtained CE Mark for its CardioSCORE™ test in Europe. The stock has extended its gains from Tuesday in trading today. At last check, BGMD was trading 5.03% higher at $3.55. Earlier in the day, the stock hit a high of $4.48 before paring its gains.
Prior to Tuesday’s rally, BGMD had been struggling to break through $1.5 level. Technical indicators for BGMD are pointing to further gains.
Find out if BGMD could maintain the momentum in the very short term by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=BGMD
Somaxon Pharmaceuticals Inc. (NASDAQ: SOMX), a specialty pharmaceutical company engaged in in-licensing, development and commercialization of branded products and late-stage product candidates, is down sharply in mid-day trading today. On Tuesday, SOMX had rallied more than 80% after the company agreed to be acquired by Pernix for $25 million in an all stock transaction.
SOMX has pared some of the gains from Tuesday in trading today. At last check, the stock was trading 7.18% lower at $2.46 on volume of 245,069, which is nearly double the daily average volume of 129,361. Year-to-date, SOMX is down more than 32%.
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
WALL STREET REPORT